JP7135218B2 - クレアチニンを検出するための分析物センサ及び検出方法 - Google Patents

クレアチニンを検出するための分析物センサ及び検出方法 Download PDF

Info

Publication number
JP7135218B2
JP7135218B2 JP2021543439A JP2021543439A JP7135218B2 JP 7135218 B2 JP7135218 B2 JP 7135218B2 JP 2021543439 A JP2021543439 A JP 2021543439A JP 2021543439 A JP2021543439 A JP 2021543439A JP 7135218 B2 JP7135218 B2 JP 7135218B2
Authority
JP
Japan
Prior art keywords
creatinine
glucose
responsive active
active region
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021543439A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022518568A (ja
Inventor
オーヤン、ティエンメイ
ジェイ． フェルドマン、ベンジャミン
チョ、ヒョン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Diabetes Care Inc
Original Assignee
Abbott Diabetes Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Diabetes Care Inc filed Critical Abbott Diabetes Care Inc
Publication of JP2022518568A publication Critical patent/JP2022518568A/ja
Priority to JP2022137913A priority Critical patent/JP7480234B2/ja
Application granted granted Critical
Publication of JP7135218B2 publication Critical patent/JP7135218B2/ja
Priority to JP2024070482A priority patent/JP7714726B2/ja
Priority to JP2025119392A priority patent/JP2025142042A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
    • A61B5/14735—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter comprising an immobilised reagent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
    • A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/002—Electrode membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
    • C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
    • C12Y105/03—Oxidoreductases acting on the CH-NH group of donors (1.5) with oxygen as acceptor (1.5.3)
    • C12Y105/03001—Sarcosine oxidase (1.5.3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/02—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
    • C12Y305/0201—Creatininase (3.5.2.10)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/03—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amidines (3.5.3)
    • C12Y305/03003—Creatinase (3.5.3.3), i.e. creatine amidinohydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
    • G01N2333/9065—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5)
    • G01N2333/90672—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5) with oxygen as acceptor (1.5.3) in general
    • G01N2333/90677—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5) with oxygen as acceptor (1.5.3) in general with a definite EC number (1.5.3.-)
    • G01N2333/90683—Sarcosine oxidase (1.5.3.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/986—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides (3.5.2), e.g. beta-lactamase (penicillinase, 3.5.2.6), creatinine amidohydrolase (creatininase, EC 3.5.2.10), N-methylhydantoinase (3.5.2.6)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Electrochemistry (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
JP2021543439A 2019-01-28 2019-09-25 クレアチニンを検出するための分析物センサ及び検出方法 Active JP7135218B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2022137913A JP7480234B2 (ja) 2019-01-28 2022-08-31 クレアチニンを検出するための分析物センサ及び検出方法
JP2024070482A JP7714726B2 (ja) 2019-01-28 2024-04-24 クレアチニンを検出するための分析物センサ及び検出方法
JP2025119392A JP2025142042A (ja) 2019-01-28 2025-07-16 クレアチニンを検出するための分析物センサ及び検出方法

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962797566P 2019-01-28 2019-01-28
US62/797,566 2019-01-28
US201962884841P 2019-08-09 2019-08-09
US201962884869P 2019-08-09 2019-08-09
US62/884,869 2019-08-09
US62/884,841 2019-08-09
US16/582,583 US20200241015A1 (en) 2019-01-28 2019-09-25 Analyte Sensors and Sensing Methods for Detecting Creatinine
US16/582,583 2019-09-25
PCT/US2019/052942 WO2020159584A1 (en) 2019-01-28 2019-09-25 Analyte sensors and sensing methods for detecting creatinine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022137913A Division JP7480234B2 (ja) 2019-01-28 2022-08-31 クレアチニンを検出するための分析物センサ及び検出方法

Publications (2)

Publication Number Publication Date
JP2022518568A JP2022518568A (ja) 2022-03-15
JP7135218B2 true JP7135218B2 (ja) 2022-09-12

Family

ID=71733450

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2021543439A Active JP7135218B2 (ja) 2019-01-28 2019-09-25 クレアチニンを検出するための分析物センサ及び検出方法
JP2022137913A Active JP7480234B2 (ja) 2019-01-28 2022-08-31 クレアチニンを検出するための分析物センサ及び検出方法
JP2024070482A Active JP7714726B2 (ja) 2019-01-28 2024-04-24 クレアチニンを検出するための分析物センサ及び検出方法
JP2025119392A Pending JP2025142042A (ja) 2019-01-28 2025-07-16 クレアチニンを検出するための分析物センサ及び検出方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022137913A Active JP7480234B2 (ja) 2019-01-28 2022-08-31 クレアチニンを検出するための分析物センサ及び検出方法
JP2024070482A Active JP7714726B2 (ja) 2019-01-28 2024-04-24 クレアチニンを検出するための分析物センサ及び検出方法
JP2025119392A Pending JP2025142042A (ja) 2019-01-28 2025-07-16 クレアチニンを検出するための分析物センサ及び検出方法

Country Status (8)

Country Link
US (1) US20200241015A1 (https=)
EP (2) EP4552566A1 (https=)
JP (4) JP7135218B2 (https=)
CN (2) CN113518584B (https=)
AU (2) AU2019427806B2 (https=)
CA (1) CA3126406A1 (https=)
ES (1) ES2999057T3 (https=)
WO (1) WO2020159584A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3423591T3 (da) 2016-03-04 2024-01-29 Abbott Diabetes Care Inc NAD(P)-afhængige sensitive enzymer, elektroder og sensorer og fremgangsmåder til fremstilling og anvendelse deraf
CN113453620B (zh) 2019-01-28 2024-03-05 美国雅培糖尿病护理公司 用于双重检测葡萄糖和乙醇的分析物传感器和感测方法
CA3126240A1 (en) 2019-01-28 2020-08-06 Abbott Diabetes Cares Inc. Analyte sensors employing multiple enzymes and methods associated therewith
EP4552566A1 (en) * 2019-01-28 2025-05-14 Abbott Diabetes Care, Inc. Analyte sensors and sensing methods for detecting creatinine
EP4574038A3 (en) 2019-01-28 2025-08-27 Abbott Diabetes Care, Inc. Analyte sensors and sensing methods featuring dual detection of glucose and ketones
CN115038381A (zh) 2020-01-03 2022-09-09 美国雅培糖尿病护理公司 用于检测多种分析物的传感器阵列系统和方法
JP7397222B2 (ja) 2020-05-29 2023-12-12 アボット ダイアベティス ケア インコーポレイテッド ジアホラーゼの阻害剤を検出するための分析物センサおよびセンシング方法
EP4165400A4 (en) 2020-06-16 2024-07-10 Abbott Diabetes Care Inc. ANALYTICAL SENSORS WITH WORKING ELECTRODE APERITY PLANING TO REDUCE INTERFERING SIGNALS
CA3181614A1 (en) 2020-06-16 2021-12-23 Abbott Diabetes Care Inc. Analyte sensors featuring a reduced-area working electrode for decreasing interferent signal
JP2023534645A (ja) 2020-07-08 2023-08-10 アボット ダイアベティス ケア インコーポレイテッド 干渉信号を低減するための強化を特徴とする検体センサ
AU2021410547B2 (en) 2020-12-23 2025-12-18 Abbott Diabetes Care Inc. Analyte sensors with reduced interferent signal and methods
WO2023178170A2 (en) * 2022-03-16 2023-09-21 Senseonics, Incorporated Catalytic reactive oxygen species scavenger hydrogel
WO2023235444A1 (en) * 2022-06-01 2023-12-07 Dexcom, Inc. Systems and methods for optimizing treatment using physiological profiles
CN120201995A (zh) 2022-12-30 2025-06-24 雅培糖尿病护理公司 药物递送组合物和控制皮下传感器的药物递送速率的方法
EP4655412A2 (en) 2023-01-25 2025-12-03 Abbott Diabetes Care, Inc. Temperature-insensitive membranes for analyte sensors
CN121174989A (zh) 2023-05-24 2025-12-19 雅培糖尿病护理公司 用于将治疗剂结合到分析物传感器中的方法
WO2025040616A1 (en) * 2023-08-22 2025-02-27 Roche Diagnostics Gmbh Sensor for detecting a plurality of analytes

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000065791A (ja) 1988-11-14 2000-03-03 I Stat Corp 完全マイクロ加工バイオセンサーのための マイクロ施与システム
JP2002501195A (ja) 1998-01-23 2002-01-15 アイ−スタット コーポレイション 微細組立された開口付きセンサー
JP2009533060A (ja) 2006-04-14 2009-09-17 ヘリコス バイオサイエンシーズ コーポレイション 核酸配列決定の正確さを増加する方法
US20110139634A1 (en) 2009-12-14 2011-06-16 Taidoc Technology Corporation System and method for measuring analyte concentration with interferant correction
US20140262776A1 (en) 2013-03-15 2014-09-18 Abbott Point Of Care Inc. Biosensor with improved interference characteristics
JP2016510218A (ja) 2013-02-08 2016-04-07 コーネル ユニバーシティー 生体分子処理プラットフォーム及びその使用
JP2016154566A (ja) 2013-03-08 2016-09-01 ザ・キャソリック・ユニバーシティ・オブ・アメリカＴｈｅ Ｃａｔｈｏｌｉｃ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ａｍｅｒｉｃａ バクテリオファージｔ４ ｄｎａパッケージングマシンを用いた遺伝子およびタンパク質のインビトロおよびインビボ送達
JP2016224075A (ja) 2013-05-02 2016-12-28 アークレイ株式会社 測定装置、及び測定方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2781980B2 (ja) * 1988-05-31 1998-07-30 電気化学計器株式会社 測定電極並びに該電極を用いた過酸化物濃度の測定方法及び基質又は有機物濃度の測定方法
WO1991000863A1 (en) * 1989-07-07 1991-01-24 Pfizer Inc. Heteroaryl piperazine antipsychotic agents
CA2017524A1 (en) * 1989-07-21 1991-01-21 Richard L. Detwiler Dry creatinine analytical element and method for its use
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US6134461A (en) 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US6241863B1 (en) * 1998-04-27 2001-06-05 Harold G. Monbouquette Amperometric biosensors based on redox enzymes
US8444834B2 (en) 1999-11-15 2013-05-21 Abbott Diabetes Care Inc. Redox polymers for use in analyte monitoring
US8268143B2 (en) 1999-11-15 2012-09-18 Abbott Diabetes Care Inc. Oxygen-effect free analyte sensor
DE60035123T2 (de) 1999-11-15 2008-01-31 Therasense, Inc., Alameda Übergangsmetallkomplexe, die über ein bewegliches zwischenglied an ein polymer gebunden sind
US7501053B2 (en) 2002-10-23 2009-03-10 Abbott Laboratories Biosensor having improved hematocrit and oxygen biases
ES2336343T3 (es) * 2004-10-05 2010-04-12 Siemens Healthcare Diagnostics Inc. Biosensor de creatinina estable para tres enzimas.
US8620398B2 (en) * 2008-06-02 2013-12-31 Abbott Diabetes Care Inc. Reference electrodes having an extended lifetime for use in long term amperometric sensors
EP2473963A4 (en) 2009-08-31 2014-01-08 Abbott Diabetes Care Inc MEDICAL DEVICES AND METHOD
US20120181189A1 (en) * 2009-09-24 2012-07-19 Fresenius Medical Care Holdings, Inc. Amperometric Creatinine Biosensor With Immobilized Enzyme-Polymer Composition And Systems Using Same, And Methods
EP2608715B1 (en) * 2010-08-24 2016-06-22 Microchips, Inc. Implantable biosensor device and methods of use thereof
FI3954781T3 (fi) * 2010-12-09 2024-10-08 Abbott Diabetes Care Inc Analyyttiantureita, joissa on havaintopinta, jossa on pieniä havaintopisteitä
US9487811B2 (en) * 2013-03-15 2016-11-08 Abbott Point Of Care Inc. Biosensor structures for improved point of care testing and methods of manufacture thereof
DE202018006591U1 (de) * 2017-08-18 2021-07-21 Abbott Diabetes Care, Inc. Systeme und Vorrichtungen betreffend die individualisierte Kalibrierung und/oder Herstellung von medizinischen Vorrichtungen
JP7011906B2 (ja) * 2017-08-25 2022-01-27 国立大学法人 筑波大学 クレアチニンセンサ
US11744492B2 (en) * 2018-08-29 2023-09-05 Medtronic, Inc. Electrochemical sensor including multiple work electrodes and common reference electrode
EP4552566A1 (en) * 2019-01-28 2025-05-14 Abbott Diabetes Care, Inc. Analyte sensors and sensing methods for detecting creatinine
EP3948249A4 (en) * 2019-03-24 2023-11-22 Baldwa, Mehul BIOSENSOR FOR DETECTING ANALYTES IN A FLUID

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000065791A (ja) 1988-11-14 2000-03-03 I Stat Corp 完全マイクロ加工バイオセンサーのための マイクロ施与システム
JP2002501195A (ja) 1998-01-23 2002-01-15 アイ−スタット コーポレイション 微細組立された開口付きセンサー
JP2009533060A (ja) 2006-04-14 2009-09-17 ヘリコス バイオサイエンシーズ コーポレイション 核酸配列決定の正確さを増加する方法
US20110139634A1 (en) 2009-12-14 2011-06-16 Taidoc Technology Corporation System and method for measuring analyte concentration with interferant correction
JP2016510218A (ja) 2013-02-08 2016-04-07 コーネル ユニバーシティー 生体分子処理プラットフォーム及びその使用
JP2016154566A (ja) 2013-03-08 2016-09-01 ザ・キャソリック・ユニバーシティ・オブ・アメリカＴｈｅ Ｃａｔｈｏｌｉｃ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ａｍｅｒｉｃａ バクテリオファージｔ４ ｄｎａパッケージングマシンを用いた遺伝子およびタンパク質のインビトロおよびインビボ送達
US20140262776A1 (en) 2013-03-15 2014-09-18 Abbott Point Of Care Inc. Biosensor with improved interference characteristics
JP2016224075A (ja) 2013-05-02 2016-12-28 アークレイ株式会社 測定装置、及び測定方法

Also Published As

Publication number Publication date
JP7480234B2 (ja) 2024-05-09
AU2019427806B2 (en) 2023-06-01
EP3917392B1 (en) 2024-09-18
EP3917392A1 (en) 2021-12-08
JP2024091894A (ja) 2024-07-05
JP7714726B2 (ja) 2025-07-29
AU2023222891A1 (en) 2023-09-14
JP2025142042A (ja) 2025-09-29
WO2020159584A1 (en) 2020-08-06
ES2999057T3 (en) 2025-02-24
CA3126406A1 (en) 2020-08-06
EP4552566A1 (en) 2025-05-14
CN113518584A (zh) 2021-10-19
JP2022518568A (ja) 2022-03-15
AU2019427806A1 (en) 2021-08-19
US20200241015A1 (en) 2020-07-30
CN119454012A (zh) 2025-02-18
JP2022172249A (ja) 2022-11-15
CN113518584B (zh) 2024-11-08

Similar Documents

Publication Publication Date Title
JP7135218B2 (ja) クレアチニンを検出するための分析物センサ及び検出方法
JP7654622B2 (ja) 乳酸センサー及び関連する方法
JP7807512B2 (ja) 複数被検物質を検出するためのセンサアレイシステムおよび方法
JP7634121B2 (ja) グルコースとケトンの二重検出を特徴とする分析対象物センサー及び検出方法
JP7690657B2 (ja) 低電位検出を特徴とする被検物質センサおよび検知方法
US9968284B2 (en) Anti-interferent barrier layers for non-invasive transdermal sampling and analysis device
JP7758718B2 (ja) ジアホラーゼ阻害剤のレベルをモニタリングするための方法
US20250152057A1 (en) Sensor having dual lactate-responsive active areas and methods for determining variance

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210827

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210827

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220714

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220802

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220831

R150 Certificate of patent or registration of utility model

Ref document number: 7135218

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250